1 – 10 of 17
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Second and third TNF inhibitors in European patients with axial spondyloarthritis : effectiveness and impact of the reason for switching
- Contribution to journal › Article
-
Mark
Predictors of DAPSA28 remission in patients with psoriatic arthritis initiating a first TNF inhibitor : results from 13 European registries
- Contribution to journal › Article
- 2023
-
Mark
Methotrexate treatment in early psoriatic arthritis in comparison to rheumatoid arthritis : an observational nationwide study
- Contribution to journal › Article
-
Mark
The National Prevalence of Clinically Diagnosed Psoriatic Arthritis in Sweden in 2017
- Contribution to journal › Article
-
Mark
Safety of biological and targeted synthetic disease-modifying antirheumatic drugs for rheumatoid arthritis as used in clinical practice : Results from the ARTIS programme
Frisell, Thomas ; Bower, Hannah ; Morin, Matilda ; Baecklund, Eva ; Di Giuseppe, Daniela ; Delcoigne, Benedicte ; Feltelius, Nils ; Forsblad-D'Elia, Helena ; Lindqvist, Elisabet LU
and Lindström, Ulf
, et al.
(2023)
In Annals of the Rheumatic Diseases
82(5).
p.601-610
- Contribution to journal › Article
-
Mark
Are JAKis more effective among elderly patients with RA, smokers and those with higher cardiovascular risk? A comparative effectiveness study of b/tsDMARDs in Sweden
Bower, Hannah ; Frisell, Thomas ; di Giuseppe, Daniela ; Delcoigne, Benedicte ; Lindström, Ulf LU ; Turesson, Carl LU ; Chatzidionysiou, Katerina ; Lindqvist, Elisabet LU
; Knight, A.
and Forsblad-d'Elia, Helena
, et al.
(2023)
In RMD Open
9(4).
- Contribution to journal › Article
-
Mark
Uptake and effectiveness of newer biologic and targeted synthetic disease-modifying antirheumatic drugs in psoriatic arthritis : results from five Nordic biologics registries
- Contribution to journal › Article
-
Mark
Differences and similarities between the EULAR/ASAS-EULAR and national recommendations for treatment of patients with psoriatic arthritis and axial spondyloarthritis across Europe
- Contribution to journal › Scientific review
- 2022
-
Mark
Comparison of treatment retention of originator vs biosimilar products in clinical rheumatology practice in Sweden
Di Giuseppe, Daniela ; Lindstrom, Ulf ; Bower, Hannah ; Delcoigne, Bénédicte ; Frisell, Thomas ; Chatzidionysiou, Katerina ; Sjöwall, Christopher ; Lindqvist, Elisabet LU
and Askling, Johan
(2022)
In Rheumatology (Oxford, England)
61(9).
p.3596-3605
- Contribution to journal › Article
-
Mark
Real-World Six- and Twelve-Month Drug Retention, Remission, and Response Rates of Secukinumab in 2,017 Patients With Psoriatic Arthritis in Thirteen European Countries
- Contribution to journal › Article